These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 14712216)

  • 21. RET/PTC activation in hyalinizing trabecular tumors of the thyroid.
    Papotti M; Volante M; Giuliano A; Fassina A; Fusco A; Bussolati G; Santoro M; Chiappetta G
    Am J Surg Pathol; 2000 Dec; 24(12):1615-21. PubMed ID: 11117781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas.
    Jhiang SM; Sagartz JE; Tong Q; Parker-Thornburg J; Capen CC; Cho JY; Xing S; Ledent C
    Endocrinology; 1996 Jan; 137(1):375-8. PubMed ID: 8536638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Rearrangement of the RET gene in papillary thyroid carcinoma].
    Wiench M; Włoch J; Oczko M; Gubała E; Jarzab B
    Wiad Lek; 2001; 54 Suppl 1():64-71. PubMed ID: 12182064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC.
    Pierotti MA; Santoro M; Jenkins RB; Sozzi G; Bongarzone I; Grieco M; Monzini N; Miozzo M; Herrmann MA; Fusco A
    Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1616-20. PubMed ID: 1542652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RET/PTC1 oncogene signaling in PC Cl 3 thyroid cells requires the small GTP-binding protein Rho.
    Barone MV; Sepe L; Melillo RM; Mineo A; Santelli G; Monaco C; Castellone MD; Tramontano D; Fusco A; Santoro M
    Oncogene; 2001 Oct; 20(48):6973-82. PubMed ID: 11704822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma.
    Rhoden KJ; Unger K; Salvatore G; Yilmaz Y; Vovk V; Chiappetta G; Qumsiyeh MB; Rothstein JL; Fusco A; Santoro M; Zitzelsberger H; Tallini G
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2414-23. PubMed ID: 16595592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A t(10;17) translocation creates the RET/PTC2 chimeric transforming sequence in papillary thyroid carcinoma.
    Sozzi G; Bongarzone I; Miozzo M; Borrello MG; Blutti MG; Pilotti S; Della Porta G; Pierotti MA
    Genes Chromosomes Cancer; 1994 Apr; 9(4):244-50. PubMed ID: 7519046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of signal transducer and activator of transcription 3 by oncogenic RET/PTC (rearranged in transformation/papillary thyroid carcinoma) tyrosine kinase: roles in specific gene regulation and cellular transformation.
    Hwang JH; Kim DW; Suh JM; Kim H; Song JH; Hwang ES; Park KC; Chung HK; Kim JM; Lee TH; Yu DY; Shong M
    Mol Endocrinol; 2003 Jun; 17(6):1155-66. PubMed ID: 12637586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RET/PTC rearrangement in thyroid tumors.
    Nikiforov YE
    Endocr Pathol; 2002; 13(1):3-16. PubMed ID: 12114746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RET/papillary thyroid carcinoma oncogenic signaling through the Rap1 small GTPase.
    De Falco V; Castellone MD; De Vita G; Cirafici AM; Hershman JM; Guerrero C; Fusco A; Melillo RM; Santoro M
    Cancer Res; 2007 Jan; 67(1):381-90. PubMed ID: 17210721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of RET oncogene activation in human papillary thyroid carcinomas by in situ hybridisation.
    Fabien N; Paulin C; Santoro M; Berger N; Grieco M; Galvain D; Barbier Y; Dubois PM; Fusco A
    Br J Cancer; 1992 Dec; 66(6):1094-8. PubMed ID: 1457350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas.
    Lanzi C; Borrello MG; Bongarzone I; Migliazza A; Fusco A; Grieco M; Santoro M; Gambetta RA; Zunino F; Della Porta G
    Oncogene; 1992 Nov; 7(11):2189-94. PubMed ID: 1437145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A.
    Bongarzone I; Monzini N; Borrello MG; Carcano C; Ferraresi G; Arighi E; Mondellini P; Della Porta G; Pierotti MA
    Mol Cell Biol; 1993 Jan; 13(1):358-66. PubMed ID: 7678053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High frequency of rearrangement of the RET protooncogene (RET/PTC) in Chinese papillary thyroid carcinomas.
    Lee CH; Hsu LS; Chi CW; Chen GD; Yang AH; Chen JY
    J Clin Endocrinol Metab; 1998 May; 83(5):1629-32. PubMed ID: 9589668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breakpoint characterization of the ret/PTC oncogene in human papillary thyroid carcinoma.
    Smanik PA; Furminger TL; Mazzaferri EL; Jhiang SM
    Hum Mol Genet; 1995 Dec; 4(12):2313-8. PubMed ID: 8634704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RET/PTC-induced gene expression in thyroid PCCL3 cells reveals early activation of genes involved in regulation of the immune response.
    Puxeddu E; Knauf JA; Sartor MA; Mitsutake N; Smith EP; Medvedovic M; Tomlinson CR; Moretti S; Fagin JA
    Endocr Relat Cancer; 2005 Jun; 12(2):319-34. PubMed ID: 15947106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Radiation-induced thyroid carcinomas in children: high prevalence of RET rearrangement].
    Rabes HM; Klugbauer S
    Verh Dtsch Ges Pathol; 1997; 81():139-44. PubMed ID: 9474864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular genetics of childhood papillary thyroid carcinomas after irradiation: high prevalence of RET rearrangement.
    Rabes HM; Klugbauer S
    Recent Results Cancer Res; 1998; 154():248-64. PubMed ID: 10027005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New breakpoints in both the H4 and RET genes create a variant of PTC-1 in a post-Chernobyl papillary thyroid carcinoma.
    Elisei R; Romei C; Soldatenko PP; Cosci B; Vorontsova T; Vivaldi A; Basolo F; Cherstvoy ED; Pinchera A; Pacini F
    Clin Endocrinol (Oxf); 2000 Jul; 53(1):131-6. PubMed ID: 10931090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thyroid carcinomas in RET/PTC transgenic mice.
    Jhiang SM; Cho JY; Furminger TL; Sagartz JE; Tong Q; Capen CC; Mazzaferri EL
    Recent Results Cancer Res; 1998; 154():265-70. PubMed ID: 10027006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.